Amiglyde-V Intrauterine Solution, 250mg/mL

Supplied By: Zoetis (10004013)


SKU
004110


Unit of
Measure
48 mL


Pack
Type
Vial


Case
Qty
24

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Oct- 2026 Sep- 2026 Aug- 2026 Jul- 2026 Jun- 2026 May- 2026 Apr- 2026 Mar- 2026 Feb- 2026 Jan- 2026 Dec- 2025 Nov- 2025 Oct- 2025
{{purchaseHistoryItem}}


SKU
004110


Size
48 mL

Case
Qty
24

Purchase History

Oct- 2026 {{productPurchaseHistory['004110'][0]}} Mar- 2026 {{productPurchaseHistory['004110'][0+7]}}
Sep- 2026 {{productPurchaseHistory['004110'][1]}} Feb- 2026 {{productPurchaseHistory['004110'][1+7]}}
Aug- 2026 {{productPurchaseHistory['004110'][2]}} Jan- 2026 {{productPurchaseHistory['004110'][2+7]}}
Jul- 2026 {{productPurchaseHistory['004110'][3]}} Dec- 2025 {{productPurchaseHistory['004110'][3+7]}}
Jun- 2026 {{productPurchaseHistory['004110'][4]}} Nov- 2025 {{productPurchaseHistory['004110'][4+7]}}
May- 2026 {{productPurchaseHistory['004110'][5]}} Oct- 2025 {{productPurchaseHistory['004110'][5+7]}}
Apr- 2026 {{productPurchaseHistory['004110'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Amiglyde-V® is indicated for the treatment of uterine infections (endometritis, metritis and pyometra) in mares, when caused by susceptible organisms including Escherichia coli, Pseudomonas sp and Klebsiella sp. The use of Amiglyde-V in eliminating infections caused by the above organisms has been shown clinically to improve fertility in infected mares.

Features & Benefits

  • Plasma protein binding of sulfadimethoxine is high, creating a drug reservoir in the blood that maintains higher blood levels than most other long-acting sulfonamides
  • A single, daily dose gives rapid and sustained therapeutic blood levels for 24 hours
  • Daily dosing increases likelihood of compliance, potentially improving outcomes
  • Available as a tablet and a palatable custard-flavored suspension that eases administration